[sunset] |
This week, Kerem Tech, a group bringing together startups, entrepreneurs
and freelancers in the technology field in northern Israel, arranged an event
at which representatives from several startups in the FemTech field presented current developments in matters of vital importance to women. The lectures
discussed new treatments for endometriosis (EndoSpot), a better
method for choosing the best embryo in IVF treatments (Carmel Diagnostics) and a developing solution for the need to prevent the release of cancer cells
during hysterectomies (Ark Surgical Ltd.) It was a fascinating
evening in terms of personal relevance, a view of the process of the medical
research and exposure to the passion of people working to improve people’s lives.
During the lectures, I discovered
that, beyond my business reason for attending, I had personal, grantedly
third-handedly, interest and experience with these issues. My daughter is among
the estimated 10% of women with endometriosis. The treatment discussed may
provide her with a future with less pain and a greater chance to have a child.
Furthermore, her mother and I went through three years of the IVF rollercoaster
ride of hope and disappointment. The method of embryo analysis being developed
may significantly increase the 25% current rate of success of IVF. Finally, it
was rather shocking to discover that a women’s risk of dying as a result of rather common hysterectomy surgery was far higher than I imagined. The company is trying to develop
a much more reliable system of preventing the release of unknown cancer cells
into the rest of the body. Although I was there to market my translation
services, the subjects of the lectures were of far more interest.
At the same time, one reality somewhat mitigated the hope raised by all these
developments, namely the lengthy time and effort required to make them
available to the market. Each of the presenters described the long serious of
tests and approvals that they had conducted and received and hinted at the
those that need to be done and attained. Consequently, they emphasized the need
for medical startups to take the long view in terms of organization, financing
and cooperation with government bodies and large private companies. Clearly,
given the size of the potential market due to the number of women suffering
these problems, the long-term effort is viable but success requires patience
and endurance.
Beyond any specific information I received, the evening encouraged me. I
was extremely impressed that these individuals and all their colleagues view
the current situation as a basis and need for change and strive to improve the
lives of women and their partners through technology. As implicit in the word
“hope”, this betterment may be in the future but it is a future that will
become the present. In a world that is rather dark now, a glimpse into the
minds of the people involved in startups is a ray of light.
Thus, the Kerem Tech event was far more than a marketing opportunity; it
was a look into the not-so-distant future where more women and men will enjoy a family in good health. If you will, it was a peak into the future just over the
horizon, giving hope to countless people.